SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LiveWire who wrote (55102)2/11/1999 8:05:00 PM
From: QuietWon   of 119973
 
About prices, when CYCH around 14 area, someone bot 5,000 at 15 -- that person must have made a typo on their order. Very temporarily, the bid-ask, for however infinitessimily (i can't spell tonight - coming off the flu) small amount of time went from 14 x 15 in a rather tight mkt. Likely someone made a typo on ENMD.

Why the heck is everyone so hot and bothered about ENMD - still in phase II, still on mice. IMCL awaiting entry of phase III (and news today from CEO confirms it's coming), works on humans, 100% of persons in the trials had their tumors shrink by more than half, 88% had complete ie.100% disappearance of their tumours. Product is way closer to market than enmd. You heard the CEO it's a hundreds of millions market each year. Their drug C225 can be used in several areas of the body they believe, each needing separate FDA approval, so they have 'multi-products'. They have a lot of CASH - from their financial partner Merck. And yet ENMD's product very far behind, doesn't work, etc moves - only b/c ppl got overzealous a yr ago and so , remember the co's name. Well, their's a new name in town - IMCL !
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext